Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanocidal Agents | 8 | 2023 | 40 | 3.810 |
Why?
|
| Trypanosoma brucei brucei | 8 | 2023 | 82 | 3.450 |
Why?
|
| Antiviral Agents | 7 | 2026 | 195 | 3.170 |
Why?
|
| Antiprotozoal Agents | 7 | 2022 | 31 | 2.630 |
Why?
|
| Biological Products | 7 | 2025 | 91 | 2.260 |
Why?
|
| Protease Inhibitors | 4 | 2026 | 54 | 2.150 |
Why?
|
| Alphavirus | 4 | 2024 | 10 | 2.070 |
Why?
|
| Viral Nonstructural Proteins | 3 | 2026 | 53 | 1.760 |
Why?
|
| Protozoan Proteins | 4 | 2016 | 191 | 1.500 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2020 | 22 | 1.440 |
Why?
|
| Cysteine Endopeptidases | 5 | 2024 | 64 | 1.300 |
Why?
|
| Quinolines | 2 | 2021 | 78 | 1.180 |
Why?
|
| Sulfones | 2 | 2020 | 47 | 1.170 |
Why?
|
| Virus Replication | 3 | 2026 | 318 | 1.130 |
Why?
|
| Molecular Structure | 9 | 2026 | 570 | 1.120 |
Why?
|
| Trypanosoma brucei rhodesiense | 3 | 2023 | 6 | 1.010 |
Why?
|
| Encephalomyelitis, Venezuelan Equine | 1 | 2026 | 3 | 0.970 |
Why?
|
| Drug Discovery | 5 | 2023 | 108 | 0.920 |
Why?
|
| Trypanosomiasis, African | 2 | 2023 | 22 | 0.890 |
Why?
|
| Structure-Activity Relationship | 6 | 2026 | 506 | 0.880 |
Why?
|
| Plant Oils | 1 | 2024 | 20 | 0.880 |
Why?
|
| Chikungunya virus | 1 | 2024 | 18 | 0.870 |
Why?
|
| Seeds | 1 | 2024 | 46 | 0.860 |
Why?
|
| Dyslipidemias | 1 | 2024 | 48 | 0.850 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2024 | 131 | 0.780 |
Why?
|
| Plant Extracts | 7 | 2021 | 302 | 0.770 |
Why?
|
| Leishmania mexicana | 3 | 2022 | 3 | 0.770 |
Why?
|
| Crops, Agricultural | 1 | 2023 | 36 | 0.760 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 184 | 0.760 |
Why?
|
| Carotenoids | 1 | 2022 | 74 | 0.740 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 1596 | 0.720 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2026 | 1124 | 0.690 |
Why?
|
| Plasmodium | 1 | 2021 | 16 | 0.680 |
Why?
|
| Leishmania | 3 | 2020 | 20 | 0.670 |
Why?
|
| Cysteine Proteases | 1 | 2020 | 2 | 0.650 |
Why?
|
| Antimalarials | 1 | 2021 | 64 | 0.650 |
Why?
|
| Terpenes | 2 | 2022 | 30 | 0.580 |
Why?
|
| Animals | 16 | 2026 | 16992 | 0.570 |
Why?
|
| Parasitic Sensitivity Tests | 4 | 2020 | 15 | 0.560 |
Why?
|
| Tabernaemontana | 1 | 2018 | 2 | 0.560 |
Why?
|
| Triterpenes | 1 | 2018 | 18 | 0.550 |
Why?
|
| Protozoan Infections | 1 | 2016 | 2 | 0.510 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 760 | 0.490 |
Why?
|
| Cathepsin L | 1 | 2015 | 15 | 0.470 |
Why?
|
| Computer Simulation | 3 | 2016 | 408 | 0.460 |
Why?
|
| Cysteine | 1 | 2015 | 103 | 0.450 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2014 | 6 | 0.440 |
Why?
|
| Alphavirus Infections | 2 | 2024 | 7 | 0.440 |
Why?
|
| Mice | 6 | 2026 | 6644 | 0.440 |
Why?
|
| Lignans | 1 | 2014 | 22 | 0.430 |
Why?
|
| Humans | 18 | 2026 | 43102 | 0.430 |
Why?
|
| Furans | 1 | 2014 | 40 | 0.430 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 2 | 2024 | 11 | 0.420 |
Why?
|
| Leishmania major | 1 | 2013 | 23 | 0.400 |
Why?
|
| Leishmaniasis | 1 | 2013 | 8 | 0.400 |
Why?
|
| Alkaloids | 1 | 2013 | 46 | 0.400 |
Why?
|
| Plants, Medicinal | 1 | 2012 | 57 | 0.360 |
Why?
|
| Fabaceae | 1 | 2011 | 30 | 0.350 |
Why?
|
| Leishmaniasis, Cutaneous | 2 | 2022 | 18 | 0.350 |
Why?
|
| Verbesina | 1 | 2010 | 1 | 0.330 |
Why?
|
| Isoflavones | 1 | 2011 | 132 | 0.330 |
Why?
|
| Coumaric Acids | 1 | 2010 | 3 | 0.330 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2011 | 134 | 0.310 |
Why?
|
| Computational Biology | 1 | 2012 | 327 | 0.310 |
Why?
|
| Plant Bark | 4 | 2011 | 8 | 0.290 |
Why?
|
| Hep G2 Cells | 2 | 2021 | 63 | 0.280 |
Why?
|
| Hydrogen Bonding | 3 | 2014 | 144 | 0.280 |
Why?
|
| Binding Sites | 4 | 2014 | 671 | 0.260 |
Why?
|
| Oxidative Stress | 2 | 2024 | 1003 | 0.260 |
Why?
|
| Plant Leaves | 2 | 2021 | 136 | 0.250 |
Why?
|
| Plants | 3 | 2023 | 113 | 0.240 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2026 | 245 | 0.220 |
Why?
|
| Gastroesophageal Reflux | 1 | 2025 | 37 | 0.220 |
Why?
|
| Pancreas | 1 | 2024 | 45 | 0.220 |
Why?
|
| Viral Structural Proteins | 1 | 2024 | 17 | 0.220 |
Why?
|
| Interleukin-1beta | 1 | 2024 | 75 | 0.210 |
Why?
|
| Indoles | 1 | 2026 | 187 | 0.210 |
Why?
|
| Microsomes, Liver | 1 | 2024 | 75 | 0.210 |
Why?
|
| Trypanosoma brucei gambiense | 1 | 2023 | 1 | 0.210 |
Why?
|
| Rats, Wistar | 1 | 2024 | 283 | 0.210 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2018 | 301 | 0.210 |
Why?
|
| Methionine-tRNA Ligase | 2 | 2013 | 2 | 0.210 |
Why?
|
| Glycerolphosphate Dehydrogenase | 2 | 2013 | 4 | 0.210 |
Why?
|
| Caenorhabditis elegans | 2 | 2014 | 80 | 0.200 |
Why?
|
| Inflammation Mediators | 1 | 2024 | 140 | 0.200 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 457 | 0.200 |
Why?
|
| Genome, Plant | 1 | 2023 | 29 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 423 | 0.200 |
Why?
|
| Plants, Genetically Modified | 1 | 2023 | 51 | 0.190 |
Why?
|
| Diphosphates | 1 | 2022 | 7 | 0.190 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2023 | 186 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2024 | 384 | 0.190 |
Why?
|
| Solvents | 1 | 2022 | 113 | 0.180 |
Why?
|
| Antiaris | 1 | 2021 | 1 | 0.180 |
Why?
|
| Potassium Cyanide | 1 | 2021 | 2 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 152 | 0.180 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2021 | 44 | 0.170 |
Why?
|
| Liver | 1 | 2024 | 511 | 0.170 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 92 | 0.170 |
Why?
|
| Quercetin | 1 | 2021 | 46 | 0.170 |
Why?
|
| Cholesterol | 1 | 2022 | 232 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 299 | 0.160 |
Why?
|
| Acetaldehyde | 1 | 2020 | 11 | 0.160 |
Why?
|
| Adenine | 1 | 2020 | 46 | 0.160 |
Why?
|
| NF-kappa B | 1 | 2022 | 358 | 0.150 |
Why?
|
| Rats | 2 | 2024 | 3735 | 0.150 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2020 | 184 | 0.150 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 269 | 0.140 |
Why?
|
| Antioxidants | 1 | 2021 | 443 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 2676 | 0.140 |
Why?
|
| Phytotherapy | 1 | 2016 | 75 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 127 | 0.120 |
Why?
|
| Models, Molecular | 2 | 2016 | 876 | 0.110 |
Why?
|
| Cell Survival | 1 | 2018 | 945 | 0.110 |
Why?
|
| Phospholipase D | 1 | 2014 | 49 | 0.110 |
Why?
|
| Olfactory Perception | 1 | 2014 | 6 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2020 | 518 | 0.100 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 97 | 0.100 |
Why?
|
| Smell | 1 | 2014 | 40 | 0.100 |
Why?
|
| Limonins | 1 | 2013 | 4 | 0.100 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2013 | 8 | 0.100 |
Why?
|
| Withanolides | 1 | 2013 | 10 | 0.100 |
Why?
|
| Static Electricity | 1 | 2013 | 86 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2014 | 134 | 0.100 |
Why?
|
| Diterpenes | 1 | 2013 | 97 | 0.100 |
Why?
|
| Africa South of the Sahara | 1 | 2012 | 52 | 0.090 |
Why?
|
| Malpighiaceae | 1 | 2011 | 1 | 0.090 |
Why?
|
| Protein Binding | 2 | 2012 | 1082 | 0.090 |
Why?
|
| Drug Design | 1 | 2013 | 186 | 0.090 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2011 | 15 | 0.090 |
Why?
|
| Ubiquitins | 1 | 2011 | 47 | 0.090 |
Why?
|
| Apigenin | 1 | 2011 | 14 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 458 | 0.090 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2011 | 58 | 0.090 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 188 | 0.080 |
Why?
|
| Monoterpenes | 1 | 2010 | 10 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2010 | 83 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2022 | 694 | 0.080 |
Why?
|
| Triose-Phosphate Isomerase | 1 | 2009 | 1 | 0.080 |
Why?
|
| Geranyltranstransferase | 1 | 2009 | 1 | 0.080 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2009 | 5 | 0.080 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2009 | 12 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 432 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1070 | 0.060 |
Why?
|
| Proton Pump Inhibitors | 1 | 2025 | 16 | 0.060 |
Why?
|
| Male | 1 | 2024 | 23409 | 0.050 |
Why?
|
| Probiotics | 1 | 2025 | 37 | 0.050 |
Why?
|
| Female | 1 | 2024 | 24698 | 0.050 |
Why?
|
| Horses | 1 | 2023 | 28 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 187 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2023 | 81 | 0.050 |
Why?
|
| Fungi | 1 | 2023 | 106 | 0.050 |
Why?
|
| Nitro Compounds | 1 | 2022 | 34 | 0.040 |
Why?
|
| Medicine, Traditional | 1 | 2021 | 23 | 0.040 |
Why?
|
| Acetamides | 1 | 2020 | 11 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2021 | 77 | 0.040 |
Why?
|
| Flavonoids | 1 | 2021 | 100 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2025 | 1604 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2023 | 2157 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 118 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 280 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2020 | 465 | 0.030 |
Why?
|
| Water | 1 | 2020 | 316 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2016 | 14 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2016 | 182 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 146 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 388 | 0.030 |
Why?
|
| Ethanolamines | 1 | 2014 | 9 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2014 | 168 | 0.030 |
Why?
|
| Starvation | 1 | 2014 | 12 | 0.030 |
Why?
|
| Escherichia coli K12 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Larva | 1 | 2014 | 133 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1180 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1542 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2011 | 416 | 0.020 |
Why?
|